ODC Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ODC Antibodies for investigating ornithine decarboxylase (ODC) in cellular processes. ODC Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ornithine decarboxylase serves as a key enzyme in the polyamine biosynthesis pathway, playing a crucial role in cell growth, differentiation, and proliferation. ODC regulation is vital for normal cellular function, while its dysregulation has been implicated in various diseases, including cancer. Understanding ODC expression and activity can provide insights into tumor biology and potential therapeutic targets. Researchers worldwide rely on ODC monoclonal antibodies to advance their studies in polyamine metabolism and cancer research. ODC investigation continues to reveal new insights into cellular growth mechanisms and disease progression. Exploring ODC function has led to significant discoveries in cancer biology and therapeutic development. Santa Cruz Biotechnology monoclonal antibodies for ODC research support scientists in making meaningful contributions to understanding cellular processes and disease mechanisms.